Australia Colonoscopy Devices Market Size and Forecast (2025–2033)

The Australia Colonoscopy Devices Market is on a steady upward trajectory, projected to rise from US$ 35.72 million in 2024 to US$ 55.84 million by 2033, expanding at a CAGR of 5.09% throughout 2025–2033. According to Renub Research, market growth is underpinned by increasing colorectal cancer cases, expanding national screening programs, technological innovations in endoscopy, and a rapidly aging population requiring routine gastrointestinal diagnostics.

As Australia strengthens its nationwide efforts to detect cancer earlier and invest in more efficient clinical infrastructure, colonoscopy devices—ranging from flexible colonoscopes to visualization systems and biopsy accessories—continue to play a vital role in gastroenterology, oncology, and preventive healthcare.

This report explores the market’s major drivers, challenges, technological innovations, product segments, and state-level trends shaping Australia’s colonoscopy landscape through 2033.

Download Free Sample Report

Australia Colonoscopy Devices Market Overview

Colonoscopy devices are essential diagnostic tools used to visually examine the interior of the colon and rectum. A typical colonoscopy system includes a flexible scope equipped with a camera, lighting system, image processor, and channels for biopsy or therapeutic tools. These devices help clinicians detect polyps, ulcers, tumors, inflammation, and early signs of colorectal cancer.

With colorectal cancer ranking among the most common cancers in Australia, colonoscopy remains the gold standard for early detection—and the demand for advanced, more patient-friendly devices continues to grow.

Public health initiatives, particularly the National Bowel Cancer Screening Program, have significantly expanded testing volumes, driving adoption across hospitals, diagnostic centers, and ambulatory surgical facilities. Moreover, the increasing elderly population and a shift toward minimally invasive diagnostics further reinforce the need for high-performance colonoscopy equipment.

Key Drivers of Growth in Australia's Colonoscopy Devices Market

1. Rising Prevalence of Colorectal Cancer

Australia has one of the highest colorectal cancer rates worldwide, making colonoscopy an indispensable diagnostic procedure in its healthcare system.

In 2020, Australia recorded 14,534 new colorectal cancer cases.

By 2024, new diagnoses were projected to rise to 15,542, affecting more than 8,200 men and 7,300 women.

The estimated lifetime risk of developing colorectal cancer by age 85 is 1 in 21 (4.8%), with men facing a slightly higher risk.

Mandatory screening for adults aged 50–74 years under the national program has dramatically increased colonoscopy demand. As early detection remains the most effective treatment approach, healthcare service providers are upgrading to HD/4K scopes, AI-assisted detection tools, and more ergonomic designs to enhance diagnostic accuracy.

With diagnostic services expanding rapidly in private clinics and public hospitals, the market is primed for strong adoption of improved colonoscopy devices that promise precision and patient comfort.

2. Aging Population and Growing Awareness of Digestive Health

Australia’s demographic profile is shifting, with a rising proportion of older adults who are more prone to gastrointestinal concerns. As of October 2023, forecasts indicated that:

By 2026, more than 22% of Australians will be over 65—up sharply from 16% in 2020.

Age-related conditions such as polyps, Crohn’s disease, and colorectal cancer make periodic colonoscopies a vital part of routine medical care. With growing public awareness, preventive screenings, dietary changes, and increased physician referrals, the demand for colonoscopy procedures is expanding across both urban and regional areas.

Healthcare providers are scaling their endoscopy capacities, investing in new imaging systems, and training specialists to meet this rising demand—thus driving consistent growth for device manufacturers.

3. Rapid Technological Advancements in Endoscopy Equipment

Innovation is one of the most transformative forces in the Australian colonoscopy market. Advanced features are reshaping procedural outcomes, patient comfort, and clinical accuracy.

Key technological advancements include:

High-definition (HD) and 4K imaging for superior visualization

AI-based polyp detection algorithms assisting clinicians in high-risk cases

Single-use colonoscopes for improved infection control and reduced reprocessing costs

Robotic-assisted endoscopy for precise navigation

Enhanced sterilization systems to reduce contamination risk

A major milestone occurred in September 2024, when Olympus Australia launched Sapphire, the country’s first flexible endoscope sterilisation plant. This initiative supports safer, more efficient endoscopy services and reduces risks and operational burdens on healthcare organizations.

As hospitals and diagnostic labs upgrade their endoscopy suites, manufacturers see growing opportunities to supply next-generation systems across Australia.

Challenges Hindering Market Growth

1. High Equipment and Maintenance Costs

Advanced colonoscopy equipment requires significant investment—not only for initial purchase, but also for:

sterilization and cleaning systems

disposable attachments

software upgrades

staff training

Smaller clinics and rural hospitals often find these costs prohibitive. Budget limitations within the public healthcare system can also delay procurement cycles, limiting the penetration of premium devices and slowing the replacement of outdated equipment.

2. Limited Access in Rural and Remote Regions

Australia’s vast geography creates healthcare disparities. Many regional and remote communities face:

shortage of specialists

older or insufficient endoscopy equipment

long waiting periods for screening

travel barriers for patients

Although mobile endoscopy units, telehealth services, and outreach programs are expanding, access remains uneven when compared with metropolitan centers. This divide impacts both patient outcomes and market potential.

Market Breakdowns by Segment

Product Segmentation

Colonoscope

Visualization Systems

Other Diagnostic & Therapeutic Accessories

Colonoscope sales constitute the backbone of the market, with growing uptake of lightweight, flexible, and disposable models. Visualization systems—especially those with 4K imaging and AI integration—are gaining traction as facilities modernize.

Application Segmentation

Colorectal Cancer (dominant share, driven by screening mandates)

Ulcerative Colitis

Crohn’s Disease

Other GI Disorders

Colorectal cancer remains the largest segment due to Australia’s strong focus on early detection and growing disease prevalence.

End User Segmentation

Hospitals

Clinics & Ambulatory Surgical Centers

Others

Hospitals account for the largest share, but ambulatory surgical centers are expanding quickly due to shorter wait times, lower costs, and increasing preference for outpatient procedures.

State-Level Market Insights

New South Wales (NSW)

As Australia’s most populous state, NSW boasts advanced medical centers with high colonoscopy volumes. Hospitals invest heavily in high-definition systems and early detection programs.

Victoria

Victoria—especially Melbourne—is a national medical research and gastroenterology hub. The state leads in:

adoption of AI-assisted colonoscopy

integration of clinical research

high patient throughput

Its strong private healthcare sector and top-tier hospitals make Victoria a major growth engine for device manufacturers.

Queensland

Queensland’s mix of urban and rural populations fuels demand for both high-end hospital systems and mobile endoscopy solutions. Government screening initiatives have further boosted procedure volumes.

Western Australia

With Perth as the center, Western Australia is witnessing rising investment in diagnostic technologies. However, its vast rural regions rely heavily on mobile units and telemedicine to improve screening accessibility.

South Australia

Adelaide serves as the state’s primary hub for colorectal cancer diagnosis and treatment. Public health campaigns and expanding screening programs drive steady demand for colonoscopy devices.

Other Territories

Australian Capital Territory: High adoption in well-equipped facilities

Tasmania: Growing demand due to aging demographics

Northern Territory: Underserved regions require portable and rugged endoscopy devices

Key Market Participants

The Australia colonoscopy devices market includes global and regional leaders offering advanced diagnostic technologies:

Boston Scientific Corporation

Fujifilm Holdings Corporation

Hoya Corporation

Medtronic plc

Olympus Corporation

Stryker Corporation

Steris Corp.

Merit Medical Systems Inc.

Getinge AB

Each company is evaluated across five vital viewpoints:

Overview

Key Personnel

Recent Developments

SWOT Analysis

Revenue Analysis

These manufacturers play a crucial role in shaping innovation, pricing, distribution, and technological advancement across Australia’s colonoscopy ecosystem.

Final Thoughts

Australia’s colonoscopy devices market is entering a period of sustained expansion, driven by rising colorectal cancer rates, national screening initiatives, and rapid advances in imaging and diagnostic technologies. While challenges persist—especially related to cost barriers and rural accessibility—the overall outlook remains positive through 2033.

Continued investment in upgraded endoscopy suites, AI-enabled devices, and patient-friendly diagnostic tools will further elevate clinical outcomes and market growth. As public awareness increases and healthcare infrastructure evolves, manufacturers have significant opportunities to deliver next-generation solutions that support Australia’s mission of early detection and improved gastrointestinal health.